AMPE Stock Summary and Trading Ideas (Ampio Pharmaceuticals | AMEX:AMPE)

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee ("OAK") as part of its OA-201 development program ("OA-201 program" or "OA-201").

Ampio Pharmaceuticals trades on the AMEX stock market under the symbol AMPE.

As of April 15, 2024, AMPE stock price was flat at $0.62 with million shares trading.

AMPE has a beta of 1.81, meaning it tends to be more sensitive to market movements. AMPE has a correlation of 0.04 to the broad based SPY ETF.

AMPE has a market cap of $703,922.00. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AMPE belongs to (by Net Assets): VXF.

AMPE has underperformed the market in the last year with a price return of -85.4% while the SPY ETF gained +25.3%. AMPE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -67.5% and -32.6%, respectively, while the SPY returned +6.2% and -3.6%, respectively.

AMPE support price is $.56 and resistance is $.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMPE stock will trade within this expected range on the day.